Pathstone Family Office’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.67M | Buy |
26,255
+7,594
| +41% | +$774K | 0.02% | 406 |
|
|
2023
Q2 | $1.87M | Sell |
18,661
-861
| -4% | -$86.4K | 0.03% | 330 |
|
|
2023
Q1 | $1.73M | Sell |
19,522
-31,926
| -62% | -$2.83M | 0.03% | 312 |
|
|
2022
Q4 | $4.14M | Buy |
51,448
+4,809
| +10% | +$387K | 0.04% | 313 |
|
|
2022
Q3 | $3.55M | Buy |
46,639
+29,924
| +179% | +$2.28M | 0.03% | 295 |
|
|
2022
Q2 | $1.41M | Buy |
16,715
+3,823
| +30% | +$323K | 0.03% | 269 |
|
|
2022
Q1 | $1.14M | Buy |
12,892
+975
| +8% | +$85.8K | 0.03% | 298 |
|
|
2021
Q4 | $1.04M | Sell |
11,917
-206
| -2% | -$18K | 0.03% | 328 |
|
|
2021
Q3 | $992K | Buy |
12,123
+1,791
| +17% | +$147K | 0.03% | 301 |
|
|
2021
Q2 | $943K | Buy |
10,332
+3,241
| +46% | +$296K | 0.03% | 285 |
|
|
2021
Q1 | $606K | Buy |
7,091
+6,323
| +823% | +$540K | 0.02% | 307 |
|
|
2020
Q4 | $73K | Buy |
768
+13
| +2% | +$1.24K | ﹤0.01% | 442 |
|
|
2020
Q3 | $66K | Hold |
755
| – | – | 0.01% | 326 |
|
|
2020
Q2 | $66K | Hold |
755
| – | – | 0.01% | 276 |
|
|
2020
Q1 | $62K | Sell |
755
-296
| -28% | -$24.3K | 0.01% | 269 |
|
|
2019
Q4 | $996K | Buy |
1,051
+296
| +39% | +$281K | 0.01% | 214 |
|
|
2019
Q3 | $66K | Hold |
755
| – | – | 0.01% | 230 |
|
|
2019
Q2 | $69K | Sell |
755
-323
| -30% | -$29.5K | 0.01% | 284 |
|
|
2019
Q1 | $93K | Buy |
1,078
+235
| +28% | +$20.3K | 0.01% | 231 |
|
|
2018
Q4 | $65K | Buy |
+843
| New | +$65K | 0.02% | 158 |
|
|
2018
Q2 | – | Sell |
-121
| Closed | -$9K | – | 273 |
|
|
2018
Q1 | $9K | Buy |
+121
| New | +$9K | 0.01% | 235 |
|
|
2017
Q3 | – | Sell |
-781
| Closed | -$59K | – | 291 |
|
|
2017
Q2 | $59K | Buy |
781
+569
| +268% | +$43K | 0.02% | 181 |
|
|
2017
Q1 | $14K | Buy |
+212
| New | +$14K | 0.01% | 257 |
|
|
2013
Q4 | – | Sell |
-73
| Closed | -$5K | – | 292 |
|
|
2013
Q3 | $5K | Sell |
73
-43
| -37% | -$2.95K | 0.02% | 220 |
|
|
2013
Q2 | $8K | Buy |
+116
| New | +$8K | 0.01% | 255 |
|